Angiocrine

We are focused on transforming medicine through the development of curative cellular therapies to treat indications in regenerative medicine.

[Angiocrine @Angiocrine]

@OTerrifying Absolutely nothing. This is nature .....just let it be.

[Angiocrine @Angiocrine]

Angiocrine Bioscience Announces First patient dosed in Pivotal Phase 3 Trial of AB-205 in Patients with Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation https://t.co/KaYYs7aXqP

[Angiocrine @Angiocrine]

@jan_nolta @UCDavisMedCntr @UCDavisEM Prayers heading your way. Get rest and take care.

[Angiocrine @Angiocrine]

Angiocrine Bioscience Announces Oral Presentation of Intravenous AB-205 Data during the Annual Transplantation & C... https://t.co/kvp8JvlJOd

[Angiocrine @Angiocrine]

Conversion of adult endothelium to immunocompetent haematopoietic stem cells - https://t.co/3U93yuxKJl

[Angiocrine @Angiocrine]

ECs sustain homestasis of resident stem cells and guide regeneration and repair of adult organs - https://t.co/3sMXCCZ1IW

[Angiocrine @Angiocrine]

Angiocrine Bioscience Announces Collaboration for Clinical Cell Manufacturing Platform with Terumo BCT https://t.co/c0bPwGDfsg

[Angiocrine @Angiocrine]

Speak up. The lives of patients like Sheldon depend on federal funding: http://t.co/NamLxD04Q4 #BeTheMatchAction

[Angiocrine @Angiocrine]

Vascular niche promotes hematopoietic multipotent progenitor formation from pluripotent stem cells.
http://t.co/BOcA9T3jQq

[Angiocrine @Angiocrine]

Angiocrine VeraVec technology to be used by WCMC researchers in the development of a cure for Sickle-Cell Anemia
https://t.co/7A68MczJaE

[Angiocrine @Angiocrine]

Activation of the vascular niche supports leukemic progression and resistance to chemotherapy
http://t.co/LAVWZ0VAIw

[Angiocrine @Angiocrine]

Tissue specific Mouse ECs for Improved Assay Performance - http://t.co/JynKgwrzua

[Angiocrine @Angiocrine]

Logo Introduced by Cord Blood Association
https://t.co/dXGLzARvha

[Angiocrine @Angiocrine]

New Association Created for Cord Blood Banking
https://t.co/Fmb3nSfPYq

[Angiocrine @Angiocrine]

Americord Funds Clinical Trial Investigating UCB Transplantation In Patients With Hematological Malignancies
http://t.co/c9C4I2fopL

[Angiocrine @Angiocrine]

Time to fund medical countermeasures against threats like Ebola http://t.co/54QTOTwjLK

[Angiocrine @Angiocrine]

2014 NIH Director's Transformative Grant Awarded to Weill Cornell Scientists
http://t.co/hRt7IMA2pu

[Angiocrine @Angiocrine]

Take a look at my new profile page. You can stop by & refer new clients anytime. http://t.co/q3N92gYh8A

[Angiocrine @Angiocrine]

Angiocrine Bioscience Licenses New Stem Cell Technology from Weill Cornell Medical College | Business Wire http://t.co/bbIA4Oq77f

[Angiocrine @Angiocrine]

Vascular bed to bedside: Engineered blood cells could cure diseases
http://t.co/GTziR8H6RB